Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial

.

Source: Expert Opinion on Biological Therapy - December 4, 2023 Category: Drugs & Pharmacology Authors: Hendrik WesselsOliver von RichterMaria VelinovaJosef H öflerPaul ChamberlainArno KrommingaDirk LehnickKarsten Rotha Polpharma Biologics S.A, Gdansk, Polandb Hexal AG (A Sandoz company), Holzkirchen, Germanyc Early Development Services, ICON, Groningen, T Source Type: research